Cumberland Pharmaceuticals, Inc.
2525 West End Avenue
Suite 950
Nashville,
TN 37203
United States - Map
Phone: 615-255-0068
Fax: 615-255-0094
Web Site: http://www.cumberlandpharma.com
| Cumberland Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The companys lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients. Cumberland Pharmaceuticals was founded in 1999 and is headquartered in Nashville, Tennessee. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. A. J. Kazimi , 51
Founder, Chairman, Chief Exec. Officer and Pres |
N/A
| N/A | Mr. David L. Lowrance , 42
Chief Financial Officer, Principal Accounting Officer and VP |
$
217.00K |
$
0 | Mr. Leo Pavliv R.Ph., 48
Sr. VP of Operations |
$
285.00K |
$
0 | Ms. Jean W. Marstiller , 59
Sr. VP and Corp. Sec. |
$
242.00K |
$
0 | Mr. Martin E. Cearnal , 64
Chief Commercial Officer, Sr. VP, Director and Member of Audit Committee |
$
80.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.21% Nasdaq 
Profile
